Liver Cancers: From Mechanisms To Management by Tim CrossLiver Cancers: From Mechanisms To Management by Tim Cross

Liver Cancers: From Mechanisms To Management

byTim CrossEditorDaniel H. Palmer

Hardcover | December 31, 2018

Pricing and Purchase Info

$212.95

Earn 1,065 plum® points

Prices and offers may vary in store

Quantity:

In stock online

Ships free on orders over $25

Not available in stores

about

This book explores in detail the primary liver cancers of hepatocellular carcinoma and cholangiocarcinoma examining the pathogenesis of disease along with diagnosis and current management options together with exploration of future treatment strategies and areas of controversy.   Furthermore, the book highlights management of the common secondary malignancies and touches on benign liver tumours and how to best manage these.  

Written in a clear and didactic style, this volume includes summaries of the key learning points and questions so that the reader can gauge their knowledge and understanding.

This book is aimed to broaden the knowledge base of primary care physicians, general physicians along with specialists in hepatology, oncology and hepato-biliary surgery

Dr Tim Cross, BMedSci (Hons), MB BS, MD, FRCPDr Cross qualified from St. Bartholomew's hospital medical college in 1996.  He undertook general gastroenterology training in North East London and hepatology training at Addenbrookes hospital, Cambridge, The Royal Free Hospital, University College Hospital and Kings College Hospital, Londo...
Loading
Title:Liver Cancers: From Mechanisms To ManagementFormat:HardcoverDimensions:312 pagesPublished:December 31, 2018Publisher:Springer NatureLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3319922157

ISBN - 13:9783319922157

Reviews

Table of Contents

Part I: Hepatocellular carcinoma (HCC).- Pathogenesis of HCC).- Surveillance for HCC.- Diagnosis of HCC.- Part II: Treatment.- Surgery.- Ablation techniques.- Transarterial chemoembolization.- Transarterial Radio-embolization.- Liver transplantation.- Chemotherapy and HCC.- Emerging novel therapies.- Part IIV: Cholangiocarcinoma.- Pathogenesis.- Diagnosis and surveillance.- Part IV:Management.- Surgery.- Ablation and embolic treatments.- Chemotherapy.- Emerging novel therapies.- Mixed Malignancies HCC/cholangiocarcinoma.- Part V: Metastatic Liver cancers.- Colorectal cancer.- Melanoma.- Neuroendocrine tumours.- Sarcomas.- Lymphoma.- Part VI: Benign Liver Tumours.- Benign Liver tumours.